Literature DB >> 16716911

In vitro effects of genistein and resveratrol on the production of interferon-gamma (IFNgamma) and interleukin-10 (IL-10) by stimulated murine splenocytes.

D Rachoń1, G Rimoldi, W Wuttke.   

Abstract

Phytoestrogens are a group of plant-derived biologically active substances with a chemical structure that resembles that of 17beta-estradiol (E2). As the presence of estrogen receptors (ER) has been identified in several immune cells, phytoestrogens may also have a great impact on the immune system. The aim of our study was to determine the in vitro effects of genistein and resveratrol on the production of interferon-gamma (IFNgamma) and interleukin-10 (IL-10) by stimulated murine splenocytes and compare them with the effects of natural E2. Phorbol 12-miristate 13-acetate (PMA) together with ionomycin was used to stimulate the cells. E2 and genistein did not show any significant effects on the stimulated production of IFNgamma. Resveratrol had a mild inhibitory effect on IFNgamma production at the concentration of 10(-7)M; however, this difference did not reach statistical significance (p>0.05). IL-10 levels in the splenocytes culture supernatants were found to be increased in the presence of E2, genistein and resveratrol; however, these effects were also not statistically significant. To determine whether the exposure to our studied phytoestrogens induced a shift in the T-helper 1/T-helper 2 (Th1/Th2) balance, we calculated the ratio between the production of IFNgamma, the prototypic Th1 cytokine, and the production of IL-10, the prototypic Th2 cytokine, at different concentrations of our tested substances. Genistein at the concentrations of 10(-6) and 10(-7)M and resveratrol at the concentrations of 10(-6)M decreased significantly the IFNgamma/IL-10 ratio. This decrease was comparable to that of E2 at the concentrations of 10(-7)M. From our in vitro experiments we conclude that genistein and resveratrol, similarly to E2, by decreasing the IFNgamma/IL10 ratio may shift the Th1/Th2 balance towards the Th2 response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16716911     DOI: 10.1016/j.phymed.2005.10.006

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

Review 1.  Metabolic effects of resveratrol: addressing the controversies.

Authors:  Jacob L Bitterman; Jay H Chung
Journal:  Cell Mol Life Sci       Date:  2014-12-30       Impact factor: 9.261

Review 2.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

Review 3.  The roles of phytochemicals in bronchial asthma.

Authors:  Hee Sun Park; So Ri Kim; Ju Ock Kim; Yong Chul Lee
Journal:  Molecules       Date:  2010-10-04       Impact factor: 4.411

4.  Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function.

Authors:  Thomas A Mace; Michael B Ware; Samantha A King; Shannon Loftus; Matthew R Farren; Elizabeth McMichael; Steven Scoville; Connor Geraghty; Gregory Young; William E Carson; Steven K Clinton; Gregory B Lesinski
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

5.  Protective effects of Vitex agnus-castus in ovariectomy mice following permanent middle cerebral artery occlusion.

Authors:  Raheleh Alimohamadi; Iman Fatemi; Soudabeh Naderi; Elham Hakimizadeh; Mohammad-Reza Rahmani; Mohammad Allahtavakoli
Journal:  Iran J Basic Med Sci       Date:  2019-09       Impact factor: 2.699

Review 6.  The protective activity of genistein against bone and cartilage diseases.

Authors:  Zhenyu Wu; Luying Liu
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

7.  RNA Expression Profile and Alternative Splicing Signatures of Genistein-Treated Breeder Hens Revealed by Hepatic Transcriptomic Analysis.

Authors:  Zengpeng Lv; Jingle Jiang; Chao Ning; Hongjian Dai; Song Jin; Xihui Wei; Debing Yu; Fangxiong Shi
Journal:  Oxid Med Cell Longev       Date:  2019-11-25       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.